Search

Your search keyword '"CD26 antigen"' showing total 396 results

Search Constraints

Start Over You searched for: Descriptor "CD26 antigen" Remove constraint Descriptor: "CD26 antigen" Publication Type Magazines Remove constraint Publication Type: Magazines
396 results on '"CD26 antigen"'

Search Results

1. Findings from National Institute of Pharmaceutical Education and Research Broaden Understanding of Information Technology (Predictive Modeling and Drug Repurposing for Type-ii Diabetes).

2. Wroclaw University of Environmental and Life Sciences Researchers Update Knowledge of Food Research [Physicochemical, Antioxidant, Organoleptic, and Anti-Diabetic Properties of Innovative Beef Burgers Enriched with Juices of Acai (Euterpe...].

3. New Chronic Kidney Disease Study Findings Reported from University of California (Impaired incretin homeostasis in non-diabetic moderate to severe chronic kidney disease).

4. "Epigenetic Modulators For Tissue Reprogramming" in Patent Application Approval Process (USPTO 20240335563).

5. Investigators at University of Western Australia Discuss Findings in Type 2 Diabetes (Cardiovascular Disease Management In Australian Adults With Type 2 Diabetes: Insights From the Capture Study).

6. Boehringer Ingelheim Pharma GmbH & Co. KG Reports Findings in Type 2 Diabetes (Pharmacometrics-Enhanced Bayesian Borrowing for Pediatric Extrapolation - A Case Study of the DINAMO Trial).

7. Universitas Jenderal Soedirman Reports Findings in Food Science and Preventive Nutrition [Precooked Jack Bean [Canavalia ensiformis (L.) DC] Sprout: Generation of Dipeptidyl Peptidase-IV Inhibitory Peptides during Simulated Digestion].

8. Recent Studies from Nanjing University Add New Data to Gene Therapy (Sensitive Detection of Dipeptidyl Peptidase Based On Dna-peptide Conjugates and Double Signal Amplification of Cha and Dnazymes).

9. New Type 2 Diabetes Data Have Been Reported by Researchers at Novo Nordisk Inc. (Adherence and Persistence Among People With Type 2 Diabetes Newly Initiating Oral Semaglutide Versus Dpp-4is In a Us Real-world Setting).

10. New Type 2 Diabetes Findings from University of Virginia Reported (Impact of Dpp4 Inhibition On Survival In Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus).

11. Findings from Attikon University Hospital Provide New Insights into Stroke (Antidiabetic Treatment and Prevention of Ischemic Stroke: A Systematic Review).

12. College of Pharmacy Researcher Updates Knowledge of Autism Spectrum Disorders (The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model).

13. New Type 2 Diabetes Findings Has Been Reported by Investigators at University of Biskra (Clinical Informatics and Molecular Hybridization of Established Clinical Dpp-4 Inhibitors To Generate Next-level Diabetes Type 2 Drugs).

14. Research in the Area of Cardiovascular Diseases and Conditions Reported from SRM Institute of Science and Technology (Exploring the Relationship of DPP-IV Inhibitors in the treatment of Diabetes and Cardiovascular Disease).

15. Bovine dendritic-cell subsets in lymphoid and non-lymphoid tissues: work in progress.

16. Study Findings from Shahid Beheshti University of Medical Sciences Provide New Insights into Chemistry (Design, Synthesis, molecular dynamic analysis, and In-Vivo anti-diabetic evaluation of novel hydrazine carboximidamide derivatives).

17. Findings from Baylor College of Medicine Broaden Understanding of Veterans Health (GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease).

18. Findings from King Saud University Broaden Understanding of Dipeptidyl Peptidase 4 Inhibitors (Miniaturized Green Capillary Electrophoresis System for the Simultaneous Analysis of Linagliptin and Cefiximein In Plasma).

19. New Findings from University of Pennsylvania in the Area of Dipeptidyl Peptidase 4 Inhibitors Described (Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase-4 Inhibitors and Serious Bleeding Events).

20. Researcher from University of Parma Details Findings in Hemangioma (CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase).

21. Monash University Researcher Adds New Findings in the Area of Epidemiology (Tree-based scan statistics to generate drug repurposing hypotheses: a test case using sodium-glucose cotransporter-2 inhibitors).

22. Data from H. Lee Moffitt Cancer Center and Research Institute Provide New Insights into Lymphoma (Implicit Flow Cytometric Diagnosis of Classic Hodgkin Lymphoma Using Cd3+cd4+cd26- T-ce.

23. Reports from Qassim University Add New Study Findings to Research in Colitis [Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles].

24. New Myotonic Dystrophy Research Has Been Reported by a Researcher at Department of Neurology (Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic...).

25. Findings in Rhabdomyolysis Reported from Isfahan University of Medical Sciences (Rosuvastatin-Induced Rhabdomyolysis as a Result of Drug Interaction With Sitagliptin: A Case Report).

26. Data on Glucose Elevating Agents Discussed by Researchers at St. Joseph's University (Synthesis and Biological Studies of 2-aminothiophene Derivatives As Positive Allosteric Modulators of Glucagon-like Peptide 1 Receptor).

27. Researchers from King Abdulaziz University Report Findings in Antidiabetic Agents (Targeting Sirt1/ampk/nrf2/nf-kb K B By Sitagliptin Protects Against Oxidative Stress-mediated Er Stress and Inflammation During Anit-induced Cholestatic Liver...).

28. Study Results from Urmia University Provide New Insights into Antidiabetic Agents (Colorimetric Detection of Sitagliptin and Moxifloxacin Using Agnps Modified By 4-mercaptophenylbronic Acid).

29. Study Results from University of Tokyo Broaden Understanding of Nephrology and Transplant Medicine (Kidney Outcomes With Sglt2 Inhibitor Versus Dpp4 Inhibitor Use In Older Adults With Diabetes).

30. Report Summarizes Proinsulin Study Findings from Fujian Normal University (Advances In Small-molecule Insulin Secretagogues for Diabetes Treatment).

31. Studies from Karolinska Institute in the Area of Type 2 Diabetes Reported (Comparative Effectiveness of Glucagon-like Peptide-1 Agonists, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas On the Risk of Dementia In Older Individuals With...).

32. Study Data from Changhua Christian Hospital Update Knowledge of Bullous Pemphigoid (A Retrospective Comparison of Diagnostic Tools of Bullous Pemphigoid for Elderly Patients).

33. Researcher from University of Tartu Reports Recent Findings in Chronic Obstructive Pulmonary Disease (Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD).

34. Diabetes Drugs Could Help Ward Off Dementia, New Study Suggests.

35. New Insulin Resistance Study Findings Have Been Reported by Investigators at Chung Shan Medical University (abelmoschus Esculentus Improves Hippocampal Function Associated With Dipeptidyl Peptidase-4 In High Fat Diet-fed Db/db Mice).

36. Researchers at Wroclaw Medical University Publish New Study Findings on HIV/AIDS (Assessment of Metabolic, Inflammatory, and Immunological Disorders Using a New Panel of Plasma Parameters in People Living with HIV Undergoing Antiretroviral...).

37. Gliclazide: Drug-induced phototoxicity: case report.

38. Findings from Chinese Academy of Sciences Update Understanding of Genomics and Genetics (New Labdane Diterpenoids From alpinia Galanga: a New Type of Glp-1 Secretagogues Targeting the Pka-creb and Pi3k-akt Signaling Axes).

39. Investigators at University of Wisconsin Describe Findings in Macular Edema (Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, and Glucagon-like Peptide 1 Receptor Agonists Do Not Worsen Diabetic Macular Edema).

40. New Nanoparticles Research from University of Management and Technology Outlined (Fabrication of novel vildagliptin loaded ZnO nanoparticles for anti diabetic activity).

41. Morinaga Milk Industry Co. Ltd. Reports Findings in Antibodies (Peptide array screening with anti-GLP-1 monoclonal antibody: Discovery of cysteine-containing DPP-IV inhibitory peptides).

42. Studies from Yunlin Further Understanding of Pharmacology (Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity).

43. Researcher from Dinajpur Describes Findings in Type 2 Diabetes (Cardioprotective effects of sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase 4 inhibitor in type 2 diabetes: A meta-analysis of comparative safety and efficacy).

44. Patent Application Titled "Compositions For Use In The Prevention And/ Or Treatment Of Intellectual Disability And Neurodegenerative Diseases In A Subject With Down Syndrome" Published Online (USPTO 20240238286).

45. Researchers from University of Santiago de Compostela Detail Findings in Adipokines (Comment On Lai Et Al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-related Gene Expression of Adipose Stromal Cells).

46. Researchers at South African Medical Research Council Have Published New Study Findings on Type 2 Diabetes (Global trends in clinical trials and interventions for the metabolic syndrome: A comprehensive analysis of the WHO International...).

47. New Lung Cancer Study Findings Have Been Reported by Investigators at Tohoku University (Dipeptidyl Peptidase 4-positive Cancer-associated Fibroblasts Enhance Lung Adenocarcinoma Growth).

48. The neonatal Fc receptor and DPP4 are human astrovirus receptors.

49. Research from Mymensingh Medical College Provides New Study Findings on Type 2 Diabetes (Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis).

50. Chung Shan Medical University Researchers Report Research in Type 2 Diabetes (Association of dipeptidyl peptidase-4 inhibitor and recurrent pancreatitis risk among patients with type 2 diabetes: A retrospective cohort study).

Catalog

Books, media, physical & digital resources